Business Context and Reporting Period
Company: Biorestorative Therapies, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 9, 2014
Event Date: September 4, 2014 to September 9, 2014
Context: The filing reports the unregistered sale of equity securities pursuant to Item 3.02.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial data disclosed relates to the specific capital raise event:
- Capital Raised: $450,000 aggregate purchase price.
- Shares Issued: 1,500,000 shares of common stock.
- Warrants Issued: 375,000 warrants exercisable at $0.75 per share with a five-year term.
Material Changes
The primary material change is the increase in outstanding common stock and the issuance of new warrants resulting from the private placement between September 4 and September 9, 2014. No other material changes to operations or financial position are detailed in this specific report.
Guidance, Outlook, and Risks
Transaction Details: The securities were issued under Section 4(a)(2) of the Securities Act of 1933 as transactions not involving a public offering. The Company did not use general solicitation or advertising.
Investor Profile: The Company reasonably believes all investors are accredited investors who had access to the Company's 2013 Form 10-K, 2014 Form 10-Qs, and other public disclosures.
Outlook: No forward-looking guidance or management commentary regarding future performance is included in this filing.
Investor Verification Checklist
- Verify the updated total share count and dilution impact following the issuance of 1,500,000 shares.
- Confirm the terms and expiration date of the 375,000 warrants issued at $0.75 per share.
- Review the Company's most recent Form 10-Q (ended June 30, 2014) for current liquidity status, as this 8-K does not provide updated cash balances.
- Assess the use of proceeds from the $450,000 raise, which is not explicitly detailed in this filing.